Sex: U
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test, Sciatica
Clinical narrative: Patient tested for Covid on 29-Nov-2023; Sciatica; This spontaneous case was reported by a patient and describes the occurrence of SCIATICA (Sciatica) and COVID-19 (Patient tested for Covid on 29-Nov-2023) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7172B) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 vaccination: Pfizer / BioNTech (Dose 1, At approximately 2:00 PM, Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot no: EN6203) on 05-Mar-2021, Pfizer / BioNTech (Dose 2, At approximately 2:00 PM, Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot no: ER8727) on 26-Mar-2021, Pfizer / BioNTech (Dose 3, At approximately 2:00 PM, Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot no: 301558A) on 28-Sep-2021, Pfizer / BioNTech (Dose 4, At 2:00 PM, Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot no: FM9992) on 23-May-2022, Pfizer Biv (Dose 5/Booster and Batch/Lot no: GH9702.) on 09-Sep-2022. Past adverse reactions to the above products included No adverse event with Pfizer / BioNTech, Pfizer / BioNTech, Pfizer / BioNTech, Pfizer / BioNTech and Pfizer Biv. Concurrent medical conditions included Asthma (when approximately 10 years old), Arthritis (when approximately 40 years old), Back pain and Hypothyroidism (Low thyroid). Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma, CELECOXIB (CELEBREX) for Back pain, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.    On 08-Jul-2023, the patient received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 01-Sep-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced SCIATICA (Sciatica). On 29-Nov-2023, the patient experienced COVID-19 (Patient tested for Covid on 29-Nov-2023). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) (oral use) from 29-Nov-2023 to 2023 at an unspecified dose and frequency. On 06-Dec-2023, COVID-19 (Patient tested for Covid on 29-Nov-2023) had resolved. At the time of the report, SCIATICA (Sciatica) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Nov-2023, SARS-CoV-2 test: Positive. On 06-Dec-2023, SARS-CoV-2 test: Negative. On 10-Dec-2023, SARS-CoV-2 test: Positive. On 19-Dec-2023, SARS-CoV-2 test: Negative.         Patient started Paxlovid on the day of first COVID positive. Before taking Paxlovid, patient had dizziness as a part of COVID symptom, but it went away after taking Paxlovid. Patient had on and off sore throat, ear pain, dry cough as COVID symptoms. Patient was COVID negative 4 days later. Then again had rebound symptoms where patient mostly felt tired with a dry cough and 9 days later tested negative for COVID-19.   Pain of sciatica relieved with Paxlovid. By the evening of 30-Nov-2023, patient had no arthritis and sciatic pain. They completely went away the entire time with Paxlovid. They came back the day patient stopped Paxlovid. Patient never got relief from Arthritis, but Sciatica resolved over next few weeks. Patient would take Paxlovid again to see if it would relieve Arthritis.